Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008216HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10026116HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048269HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048270HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052479HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052709HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30084289HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30088779HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30018326HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30026961HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB09089
Drug NameTrimebutine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs8822036
CitationsEglen RM, Watson N: Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol. 1996 Feb;78(2):59-68.
GroupsApproved
Direct ClassificationGallic acid and derivatives
SMILESCCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL190044